October 7th 2021, 11:00am
The case suggests lung transplantation can be a feasible option for patients with lung involvement.
October 6th 2021, 10:45pm
New data on treatment for newly diagnosed pulmonary arterial hypertension (PAH) show initial treatment for the progressive disease that includes macitentan has potential to reduce risk of disease progression.
October 1st 2021, 11:00pm
In patients with BRAF-mutated melanoma, achieving a complete response and circulating tumor DNA negativity are promising prognostic markers.
October 1st 2021, 5:00pm
October 1st 2021, 3:30pm
Acid sphingomyelinase deficiency (ASMD) is a rare lysosomal storage disorder; a new report said that plasma lyso-sphingomyelin levels can be used to not only diagnose the rare disease but also predict severity and type.
October 1st 2021, 1:38pm
Investigators reported comprehensive genomic features of patients with clear cell renal cell carcinoma, potentially giving providers a better understanding of the molecular features associated with the disease.
October 1st 2021, 1:15pm
Dosing from pivotal phase 3 trials of tyrosine kinase inhibitors (TKIs) in chronic myeloid leukemia (CML) is not optimal for real-world patients who experience different efficacy and adverse events (AEs).
October 1st 2021, 12:45pm
Maralixibat is the first treatment approved for cholestatic pruritus in patients with Alagille syndrome who are 1 year or older.
October 1st 2021, 11:00am
A new study suggests the lower-cost, more patient-friendly assessment method may be a useful tool for clinicians.
September 29th 2021, 9:00pm
Therapies that block adenosine triphosphate (ATP) can reduce the irritation that causes cough, and some currently being studied also don’t have taste side effects that can confound clinical trial results, explained Ron Eccles, BSc, PhD, DSc, emeritus profess at Cardiff University.
